COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 844: Articles 8431-8440  | Next

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
Yuan, M., Chen, X., Zhu, Y., Dong, X., Liu, Y., Qian, Z., Ye, L., Liu, P.
10.1101/2022.05.11.491588 — Posted: 2022-05-12
Effect on the conformations of spike protein of SARS-CoV-2 due to mutation
Mallick Gupta, A., Chakrabarti, J.
10.1101/2022.05.11.491583 — Posted: 2022-05-12
Detection Of SARS-CoV-2 Variants Of Concern In Wastewater Of Leuven, Belgium
Bloemen, M., Delang, L., Rector, A., Raymenants, J., Thibaut, J., Pussig, B., Fondu, L., Aertgeerts, B., Van Ranst, M., Van Geet, C., Arnout, J., Wollants, E.
10.1101/2022.05.12.22274823 — Posted: 2022-05-12
Factors Related to Stress in Children with Online Media Learning Methods during a Pandemic at Jaya Mulya 1 Elementary School, Karawang-Indonesia
Bayuningsih, R., Sidik, F.
10.1101/2022.04.02.22273339 — Posted: 2022-05-12
Early detection of fraudulent COVID-19 products from Twitter chatter
Sarker, A., Lakamana, S., Liao, R., Abbas, A., Yang, Y.-C., Al-Garadi, M.
10.1101/2022.05.09.22274776 — Posted: 2022-05-11
COVID-19 vaccination in pregnancy: views and vaccination uptake rates in pregnancy, a mixed methods analysis from the Born In Wales study
Mhereeg, M., Jones, H., Kennedy, J., Seaborne, M., Parker, M., Kennedy, N., Beeson, S., Zuccolo, L., Davies, A., Brophy, S.
10.1101/2022.05.09.22274769 — Posted: 2022-05-11
COVID-19 Vaccine effectiveness against symptomatic infection and hospitalization in Belgium, July 2021-April 2022
Braeye, T., van Loenhout, J. A. F., Brondeel, R., Stouten, V., Hubin, P., Billuart, M., Chung, J., Vandromme, M., Wyndham-Thomas, C., Blot, K., Catteau, L.
10.1101/2022.05.09.22274623 — Posted: 2022-05-11
Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals
Thebault, S., Lejal, N., Dogliani, A., Donchet, A., Urvoas, A., Valerio-Lepiniec, M., Lavie, M., Baronti, C., Touret, F., da Costa, B., Bourgon, C., Fraysse, A., Saint-Albin-Deliot, A., Morel, J., Klonjkowski, B., de Lamballerie, X., Dubuisson, J., Roussel, A., Minard, P., Le Poder, S., Meunier, N., Delmas, B.
10.1101/2022.05.10.491295 — Posted: 2022-05-11
Delayed antigen-specific CD4+ T cell induction correlates with impaired immune responses to SARS-COV-2 mRNA vaccination in the elderly
Jo, N., Hidaka, Y., Kikuchi, O., Fukahori, M., Sawada, T., Aoki, M., Yamamoto, M., Nagao, M., Morita, S., Nakajima, T. E., Muto, M., Hamazaki, Y.
10.1101/2022.05.10.490700 — Posted: 2022-05-11
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron-BA.2
Zhou, R., Liu, N., Li, X., Peng, Q., Yiu, C.-K., Huang, H., Yang, D., Du, Z., Kwok, H.-Y., Au, K.-K., Cai, J.-P., Hung, I. F.-N., To, K. K.-W., Xu, X., Yuen, K.-Y., Chen, Z.
10.1101/2022.05.09.491254 — Posted: 2022-05-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).